Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 3/20 | 0.72 |
| ▸ | FGFR1 | P11362 | 6/20 | 0.64 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3419279 | 0.86 | HTT (0.88) | HTTFGFR1POLBKDM4EALDH1A1 | |
| SCHEMBL30402227 | 0.86 | HTT (0.88) | HTTFGFR1POLBKDM4EALDH1A1 | |
| SCHEMBL157265 | 0.84 | HTT (1.00) | HTTFGFR1 | |
| Benzene SCHEMBL14876970 | 0.84 | HTT (1.00) | HTTFGFR1 | |
| Iodide SCHEMBL30645138 | 0.82 | HTT (0.96) | HTTFGFR1 | |
| SCHEMBL27724758 | 0.82 | HTT (0.96) | HTTFGFR1 | |
| SCHEMBL4891428 | 0.82 | HTT (0.96) | HTTFGFR1 | |
| SCHEMBL467858 | 0.82 | HTT (0.96) | HTTFGFR1 | |
| SCHEMBL2531256 | 0.81 | HTT (0.78) | HTTFGFR1POLBKDM4EALDH1A1 | |
| SCHEMBL16147268 | 0.81 | HTT (0.66) | HTTFGFR1POLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 229 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230220161-A1 | POLYIMIDE PRECURSOR PREPARED BY USING POLYCYCLIC MONOMER INCLUDING TRIFLUOROMETHYL GROUP AND FLEXIBLE POLYIMIDE OBTAINED BY USING THE SAME | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2023-07-13 | — | — | US | claimed |
| CN-115010701-A | Preparation method of nitrogen-containing heterocyclic derivative | 浙江百可半导体材料有限公司 | 2022-09-06 | — | — | CN | claimed |
| CN-114361341-A | Laminated image pickup device and image pickup module | 索尼公司 | 2022-04-15 | — | — | CN | claimed |
| CN-114316478-A | Graphene semiconductive shielding material for cable and preparation method thereof | 段恩成 | 2022-04-12 | — | — | CN | claimed |
| CN-107534050-B | Image sensor, laminated image pickup device, and image pickup module | 索尼公司 | 2021-12-14 | — | — | CN | claimed |
| US-20200274077-A1 | PHOTOELECTRIC CONVERSION ELEMENT AND IMAGING APPARATUS | SONY CORPORATION (JP) | 2020-08-27 | — | — | US | claimed |
| CN-111316459-A | Photoelectric conversion element and imaging device | 索尼公司 | 2020-06-19 | — | — | CN | claimed |
| US-10566548-B2 | Image sensor, stacked imaging device and imaging module | SONY CORPORATION (JP) | 2020-02-18 | — | — | US | claimed |
| EP-3300114-B1 | IMAGING ELEMENT, MULTILAYER IMAGING ELEMENT AND IMAGING DEVICE | SONY CORP (JP) | 2020-01-08 | — | — | EP | claimed |
| US-10076517-B2 | Methods and pharmaceutical compositions for the treatment of fibrosis | INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE KA RECHERCHE MÉDICALE (FR) | 2018-09-18 | — | — | US | claimed |
| WO-2012059442-A2 | NEUROTRYPSIN INHIBITORS | NEUROTUNE AG (CH) | 2012-05-10 | — | — | WO | claimed |
| EP-2421825-A1 | AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS | Janssen Pharmaceutica N.V. (BE) | 2012-02-29 | — | — | EP | claimed |
| EP-2421848-A1 | AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS | Janssen Pharmaceutica N.V. (BE) | 2012-02-29 | — | — | EP | claimed |
| US-20100331300-A1 | AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS | JANSSEN PHARMACEUTICA NV (BE) | 2010-12-30 | — | — | US | claimed |
| US-20100324014-A1 | AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS | JANSSEN PHARMACEUTICA NV (BE) | 2010-12-23 | — | — | US | claimed |
| CN-101875637-A | Organic material and application thereof in organic electroluminescence devices | BEIJING VISIONOX TECHNOLOGY CO | 2010-11-03 | — | — | CN | claimed |
| WO-2010124119-A1 | AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS | JANSSEN PHARMACEUTICA NV (BE) | 2010-10-28 | — | — | WO | claimed |
| WO-2010124108-A1 | AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS | JANSSEN PHARMACEUTICA NV (BE) | 2010-10-28 | — | — | WO | claimed |
| EP-1326864-A2 | ARYL OR HETEROARYL FUSED IMIDAZOLE COMPOUNDS AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS | PFIZER PHARMACEUTICALS INC. (JP) | 2003-07-16 | — | — | EP | claimed |
| WO-2002032900-A2 | ARYL OR HETEROARYL FUSED IMIDAZOLE COMPOUNDS AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS | PFIZER PHARMACEUTICALS INC. (JP) | 2002-04-25 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10076517-B2 | Methods and pharmaceutical compositions for the treatment of fibrosis | LIPA, MGLL, PNLIP | HTT 4502/4885FGFR1 828/4885POLB 3008/4885 |
| US-20100331300-A1 | AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS | PNLIP, LPL, LIPA | HTT 2522/4885FGFR1 1817/4885POLB 3399/4885 |
| US-20100324014-A1 | AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS | PNLIP, LPL, LIPA | HTT 2522/4885FGFR1 1817/4885POLB 3399/4885 |
| US-20200274077-A1 | PHOTOELECTRIC CONVERSION ELEMENT AND IMAGING APPARATUS | PPOX, JUP, L1CAM | HTT 4831/4885FGFR1 4364/4885POLB 2158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.